CLOSE X
Nidan Laboratories And Healthcare Ltd.
Issue Open Date 28-Oct-21  
Issue Closing Date 02-Nov-21  
Application Money 100  
Allotment Money  
Price Band () 125 -  
Minimum Bid Quantity. 1000  
Issue Size (Shares) 4000000  
Market Lot 1  
Objective

1) Repayment / pre-payment, in full or in part, of certain borrowings availed by our Company.2) Additional Working Capital.3) General Corporate Expenses.

Business Description

Our Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratories And Healthcare Private Limited” under the Companies Act,...

Promoter's Holding
Total Share Capital   9899400  
Offered to Public   4000000  
Promoter's Holding (Pre-Issue)   99.99  
Promoter's Holding (Post-Issue)   71.22  
Address
Address :Sy No. 294/ A H. No. 18
Swapnshilpa
Behind Aarti Apartment
Vartak Road
Virar (W)
City :Palghar, State :Maharashtra Pincode :401303 Phone :8975610000 Email : cs@nidanhealthcare.co.in Website : www.nidanhealthcare.co.in
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
NSE
Lead Manager
First Overseas Capital Ltd.
Promoters
Nithin Vitthalrao Thorave
BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

 ©  Copyrights 2022, BNK Capital Group All Rights Reserved

Designed & Developed - Accord Fintech Pvt. Ltd.